An oral, ultra-long-acting, extended-release risperidone capsule provided sustained therapeutic levels of risperidone over 1-week dosing intervals, according to results of a randomized ...

We performed a long-term comparison of a newer, atypical antipsychotic drug, risperidone, and an older, conventional neuroleptic drug, haloperidol, in terms of the rate of relapse in patients with ...

Purpose: The pharmacology, pharmaceutics, clinical efficacy, adverse effects, cost, and dosage and administration of long-acting risperidone injection are reviewed. Summary: Risperidone is the ...

Atypical antipsychotic agents, which block postsynaptic dopamine and serotonin receptors, have advantages over traditional antipsychotic medications in the treatment of adults with schizophrenia ...

Objective: To prospectively compare risperidone with conventional antipsychotic agents among schizophrenia patients treated under usual practice conditions. Design: One-year, multicentre ...

Risperidone and olanzapine were found to be equally effective for the treatment of persistent delusional disorder (PDD), according to a study published in Psychiatry Research. Currently ...

Some patients have been sickened and at least one may have died when they were inadvertantly given the antipsychotic drug risperidone (Risperdal) instead of the Parkinson’s drug Requip ...

Risperidone is a second-generation antipsychotic that lacks acute motor side effects at low doses (<6 mg/day), but above this level is associated with parkinsonism and akathesia. The literature ...

The study assessed oral weekly risperidone 15 mg and 45 mg, equivalent to 2 mg and 6 mg daily Risperdal, respectively. A total of 90 participants were planned for the study, with a planned interim ...

Ongoing research of the biochemical basis of schizophrenia identified a role for serotonin, leading to the development of atypical antipsychotic compounds such as olanzapine and risperidone ...

If you continue to have this issue please contact [email protected]. Weekly risperidone delivered via the Lynx platform achieved drug levels comparable to daily dosing. A pivotal safety ...

Presentations include data informing clinical strategies for switching patients to UZEDY, an extended-release injectable suspension of risperidone for subcutaneous use every one or two months for ...